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Abstract: In this review we discuss health measurement with a focus on psychometric methods 
and methodology. In particular, we examine some of the key issues currently facing the use 
of clinician and patient rating scales to measure the health outcomes of disease and treatment. 
We present three key facts and flag one crucial problem. First, the numbers generated by scales 
are increasingly used as the measurements of the central dependent variables upon which clinical 
decisions are frequently made. The rising profile of rating scales has significant implications for 
scale construction, evaluation, and selection, as well as for interpreting studies. Second, rating 
scale science is well established. Therefore, it is important to learn the lessons from those who 
have built and established the science over the last century. Finally, the goal of a rating scale 
is to measure. As such, over the last half century, developments in rating scale (psychometric) 
methods have caused a refocus in the way we should be measuring health. In particular, newer 
methods have significant clinical advantages over traditional approaches. These should be 
seriously considered for inclusion in everyday practice. This leads us to the central problem 
with health measurement, which is that we cannot currently be sure what most rating scales are 
measuring. This is because the methods we have in place to ensure the validity of rating scales 
fall short of what is actually required. We expand on this point, and provide some potential 
routes forward to help address this important problem.
Keywords: patient-reported outcome instruments, health-related quality of life, psychometrics, 
questionnaires, outcome assessment, health care
Introduction
Health measurement is increasingly at the heart of the agenda for high-stakes clinical 
research, trials, and practice,1–3 which directly influences decisions about patient care 
and policy-making.4 This rise in profile has been accompanied by an increased inter-
est in rating scale science.2,3 There are now growing numbers of clinical researchers 
who are either developing or using rating scales to quantify the effects of disease or 
treatment on abstract concepts, such as ability, emotional well-being, or memory. For 
example, the MAPI Trust, a nonprofit organization providing information on patient 
rating scales, houses over 3000 scales.5
Over the last 16 years we (SC, JH) have worked as health measurement researchers. 
We have been fortunate enough to have been involved in a wide range of clinical6,7 and 
surgical8,9 areas, have tested and developed a number of clinician-report10,11 and patient-
report rating scales,12,13 and have used traditional and modern rating scale techniques.14 
Our main interest lies in the science that underpins health measurement, also known as 
psychometrics.15 During our working careers, we have witnessed great progress relating Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
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to the application of psychometrics to the development of 
rating scales, and the development of documents containing 
key guidelines16,17 and high-level requirements.2,3
However, we have also witnessed concerning problems 
in the field. Thus, despite the proliferation of rating scales 
in health measurement, many scales have not been psycho-
metrically validated in an appropriate way.18–22 This has 
wide-reaching effects. For example, despite the increased 
inclusion of rating scales in current “state-of-the-art” clinical 
research and trials, the same studies continue to use scales 
that have been proved to be scientifically wanting. This is 
demonstrated through even the most superficial of literature 
reviews, ie, a brief literature search in PubMed focusing on 
randomized controlled Phase III and IV trials in multiple 
sclerosis published in 2006–2011. This reveals that half 
of the 28 relevant articles used a rating scale, but only two 
articles include scales that have any supporting psychometric 
evidence. Parallels can be seen throughout neurology,11,23 and 
our experience working in other clinical disciplines suggests 
that these problems are not uncommon.
Given the increasing importance of rating scale data, 
we strongly believe that rating scales should provide scien-
tifically robust results. However, the problem with health 
measurement runs deeper than psychometric “validation”. 
In order to understand why, we need to step back initially and 
provide some background and context. So, in this review, we 
explore health measurement, beginning with key concepts, 
followed by some important historical landmarks, then move 
on to the development and application of psychometric 
  methods, finishing with some of the pressing issues of the 
current time. Health measurement covers a lot of ground. 
Of course it would be impossible to discuss all aspects of the 
area. So, before we get started, it is important to clarify what 
we will not be discussing here, but, given the omissions, why 
we believe our title is appropriate.
First, we do not include discussions on health economics, 
clinimetrics, or specific aspects of psychometric testing. In 
relation to health economics, the extent to which this falls 
under the remit of health measurement per se is debatable, 
but more importantly, this in itself is a large area that deserves 
its own review. For those interested in our views, we discuss 
health econometrics more fully elsewhere.9
In relation to clinimetrics, we would point readers to 
another of our publications, in which we provide a perspective 
on Feinstein’s contribution to the health measurement debate.23 
For now, we would say that in this review we focus on the 
“measurement” part of health measurement. In particular, 
we discuss rating scales when they are used as   measurement 
instruments to quantify variables of   interest (eg, ability, 
depression, short-term memory) via patient self-report or 
clinician report. We do not discuss rating scales when they 
are used for other purposes, such as checklists, clinical 
assessment tools, methods of predicting outcome, structured 
interviews, or other methods for gathering information 
(eg, surveys). This is because terms such as evaluation, 
assessment, and measurement are often used interchange-
ably. However, measurement has a very specific meaning 
with respect to quantifying attributes (ie, a characteristic, or 
property belonging to a person).24 In contrast, evaluation and 
assessment are often qualitative processes.
Finally, we do not include a review (or appraisal) of specific 
psychometric tests, because once again this deserves its own 
review, given the size of the area and the issues. For those 
readers who would like to learn more, we have previously 
published a monograph that examines, in detail, the key tests 
used in traditional and modern   psychometric methods.14
Why then, given that health measurement encompasses 
such a wide area, and has potentially many good and bad 
points, do we believe that our title is appropriate? In order 
to answer this question we must anticipate the punch line of 
our review. Thus, we believe that the cornerstones of health 
measurement are the instruments used to measure the target 
variables of interest. For these instruments to be fit for pur-
pose they must provide clinically useful, meaningful, and 
interpretable data. We argue that, at the present time, the 
extent to which the vast majority of currently available scales 
achieve these vital criteria is unclear at best. This presents a 
“house of cards” situation, ie, if we are unclear as to the exact 
variables that our scales are measuring, what exactly can we 
do with the information they provide? We would suggest this 
fundamental issue has serious repercussions for the whole of 
health measurement. However, before we expand on this, we 
first need to revisit some key concepts to set the scene.
Key concepts
Rating scales are used to measure unobservable (latent) 
variables known as theoretical constructs, which are abstract 
(as opposed to concrete).25 Latent variables can be measured 
indirectly by asking questions intended to capture, empiri-
cally, the essential meaning of a construct. The simplest 
way to do this is to ask a single straightforward question, 
or item. However, single items are limited because they are: 
unlikely to represent the broad scope of a complex theoretical 
construct; likely to be interpreted in many different ways by 
respondents; imprecise because they cannot discriminate, 
to a fine degree, between different levels of an attribute; Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
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and unreliable (prone to random error) because they do not 
produce consistent answers over time.26 As such, rating scales 
are usually made up of multiple items, in which each item 
addresses a different aspect of the same underlying construct. 
Using multiple items overcomes the scientific limitations 
of single items because: more items increase the scope of 
a scale; are less open to variable interpretation; enable bet-
ter precision; and improve reliability by allowing random 
errors of measurement to average out.26 In this review, we 
use the term “rating scale” as the umbrella term to cover any 
instrument that conforms to a questionnaire-style structure, 
and is used to obtain scores, from a person’s responses to 
statements or questions, which in turn are considered to be 
measurements of a given variable.
There are many methods, termed scaling models, for 
combining multiple items into scales, depending on the 
purpose the resulting scale is to serve.27–31 The most widely 
used scaling model in health measurement is the method 
of summated ratings proposed by Likert.32,33 Four charac-
teristics constitute a summated rating scale. First, there are 
multiple items whose scores are summed, without weight-
ing, to generate a total score. Second, each item measures 
a property that can vary quantitatively. Third, each item 
has no right answer. Fourth, each item in the scale can be 
rated independently. Examples of Likert scales used in 
health measurement include the Medical Outcomes Study 
36-item Short Form Health Survey (SF-36),34,35 General 
Health Questionnaire (GHQ),36 and the Hospital Anxiety and 
Depression Scale (HADS).37 The way in which developers 
propose that items should be combined to form a scale is 
called a measurement model. These models are the focus of 
a psychometric evaluation.
Rating scales in health 
measurement: a brief history
We have come a long way since Ernest Amory Codman’s 
“end result” idea.38 Codman was an orthopedic surgeon at 
the Massachusetts General Hospital, Boston, MA, during the 
first three decades of the 20th century.39 His “end result idea” 
entailed long-term follow-up of patients to determine treat-
ment success, and taking steps to prevent new failures if 
outcomes were undesirable. Although Codman has been 
described as one of the most important figures in the history 
of clinical outcomes research, the conception and develop-
ment of his “idea” have been largely neglected in the history 
of health measurement.38,39 It was not until after the Second 
World War that clinical researchers began to develop scales 
to measure the outcomes of procedures.
One of the first surgeons to do this was Visick, who 
attempted to measure the functional results of gastric surgery, 
focusing particularly on postprocedural   complications.40 
In 1949, Karnofsky, an oncologist, developed the first 
“performance” measure,41 ie, a 10-point observer-rated scale 
spanning the extremes of physical dependency defined by 
nursing burden. For many years, this scale was used widely, 
but often, it has been argued, inappropriately.42 It was 
improved 20 years later with Katz’s Activities of Daily 
Living Scale, which broadened the focus to wider aspects 
of quality of life.43 The same period saw an increase in the 
development and use of new scales across medicine, with 
the most noticeable increase in neurology.44 The decades 
following the 1960s witnessed increasing recognition of the 
importance of assessing a broader array of outcomes when 
measuring the impact of disease or evaluating the effective-
ness of procedures.
During the 1970s, the focus of health care evaluation 
moved from traditional clinical outcomes (ie, mortality and 
morbidity) to the measurement of function (ie, the ability of 
patients to perform activities of daily living).25 The shift from 
traditional outcome measures to the wider encompassing mea-
surement of health occurred for a number reasons. First, the 
narrow definition of health in terms of morbidity and mortality 
was replaced by a broader definition of health as a “complete 
state of physical, mental and social well-being and not merely 
the absence of disease or infirmity”.45 Second, public health 
campaigns, rising standards of living, ageing populations, and 
development of health technology led to a shift in attention 
from the cure of acute diseases to the management of more 
complex, chronic conditions (eg, asthma, rheumatoid arthritis, 
multiple sclerosis). This led to increased interest in measuring 
more complex and subjective aspects of outcomes pertaining 
to the health impact of disease and/or treatment (for which 
we use the shorthand term “health outcomes” in this review). 
Third, there was increased demand for clinicians to demon-
strate evidence of cost-effectiveness, in which the benefits of 
a particular health service or intervention are weighed against 
the costs of that service or intervention.46
The 1980s witnessed patient report rating scales (now 
known as Patient Reported Outcome [PRO] instruments) 
being increasingly used in clinical research, and as a result, 
phrases such as “quality of life” became buzz words.47 Scales 
for use across different clinical populations (generic mea-
sures) were developed and became widely used, including 
the Sickness Impact Profile,48 Nottingham Health Profile,49 
and SF-36.50 The 1990s saw a proliferation of more tar-
geted patient rating scales, including dimension-specific Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
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(eg, mood37), disease-specific (eg, cancer51), site-specific 
(eg, orthopedic52), and individualized scales.53 The gradual 
but important shift from clinical research to practice and 
policy2–4 over the last decade has witnessed the proposal of 
even more sophisticated measuring instruments in the form 
of item banks.54–56
Rating scales in health 
measurement: type and kind
Philosophically, the different types of rating scales can be 
classified into two distinct approaches.57,58 First, the standard 
needs approach describes measuring health outcomes as the 
extent to which certain universal needs are met. This approach 
advocates that there is a standard set of life circumstances 
that are required for optimal functioning. Although subjective 
phenomena, health outcomes are objective characteristics 
of an individual. Second, and in contrast, the psychological 
processes approach views health outcomes as being con-
structed from individual evaluations of personally salient 
aspects of life. This approach sees health outcomes as being 
made up of perception of life circumstances, dependent on 
the psychological makeup of an individual, rather than on 
their life circumstances alone. The central assumption of this 
approach is that each person is the best source of judgments 
about health outcomes, and one cannot assume that all people 
will value different circumstances in the same way.
Many types of rating scales can be classed as following 
the standard needs approach, ranging from generic scales that 
  provide comprehensive, general evaluations of health out-
comes, to those that concentrate on a specific aspect of health 
(eg, symptoms). The former is illustrated by the SF-36,50 which 
focuses on activities of daily living (eg, personal care, domestic 
roles, mobility) and on role functioning (eg, work, finance, 
family, friends, and social). Generic measures permit direct 
comparisons of different patient populations, thereby provid-
ing the opportunity to make policy decisions across a variety 
of diseases.59 The use of generic measures may enhance the 
generalizability of a study or help interpret results in a wider 
context. In addition, it can be argued that generic measures are 
likely to be robust because they are used and tested in many 
different settings. However, generic measures may be limited 
because they are may be unable to address important aspects 
of outcome that are affected by a particular disease, and may 
not be sensitive enough to detect changes in outcome which 
occur in response to treatment or over time.60
There are three types of standard needs rating scales that 
concentrate on a more specific aspect of health, ie, disease/
condition-specific, site-specific, and dimension-specific. 
The most commonly used of these scales are disease/
condition-specific scales, which are developed for use in a 
specific disease or condition. These include items that are 
directly relevant to the condition and, therefore, are likely 
to be shorter and apparently more appropriate,59 which can 
help to reduce patient burden and increase acceptability.61 
Disease-specific scales ensure more comprehensive assess-
ment of important outcome domains, and are generally more 
sensitive in detecting the effects of treatment on outcome and 
changes in outcome over time.59
A site-specific scale focuses on health problems in a 
specific part of the body, such as the Oxford Hip Score.52 As 
with disease/condition-specific scales, these include fewer 
items and appear to be more appropriate, reducing patient 
burden and increasing acceptability.
A dimension-specific scale provides a comprehensive, 
general evaluation of one specific aspect of health, which may 
be applicable across different patient groups and   treatments. 
Examples of these types of scale include the GHQ62 and 
HADS37 which focus on aspects of psychological well-being. 
The advantage of such measures is that they provide a more 
detailed assessment in the area of concern.
The main drawback of specific measures is that they do 
not allow comparisons between different patient groups. 
Therefore, it is argued that comprehensive assessment of 
outcome should include a combination of generic and specific 
measures.59,60 Generic measures allow comparisons across 
studies, thus enhancing the generalizability of findings, and 
specific measures provide better content validity, so are gen-
erally more responsive to measuring change due to greater 
relevance to the specific population.
In contrast to using generic or specific rating scales with 
predetermined content, proponents of the psychological pro-
cesses approach argue that listing items in rating scales do not 
capture the subjectivity of human beings and the individual 
structure of values. In short, prescribing items using a preor-
dained definition of health outcome (eg, quality of life) and 
matching the person to the definition (ie, “goodness of fit”), 
does not let us know whether all the domains, pertinent and 
meaningful to each respondent, are included. This viewpoint 
prompted the development of “individualized” measures, 
such as the Schedule for the Evaluation of Individual Qual-
ity Of Life (SEIQoL).53 The SEIQoL allows individuals to 
nominate important domains of quality of life and weight 
those domains in order of importance. Another, the Patient 
Generated Index (PGI), asks individuals to identify those 
aspects of life that are personally affected by health.63 
The main advantage of these measures includes a claim Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
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for validity, given that the areas of   importance are selected 
by the individuals involved in completing the measures. The 
main disadvantages are that some of these measures require 
trained interviewers, which translates into a need for greater 
resources and lower   practicality. Also, it is less easy to com-
pare data from individualized measures between patients due 
to the variation in each individual completed measure.64
Item banks can be viewed as very large “rating scales”, 
in which patients only complete a subset of targeted items. 
These banks capitalize on modern psychometric methods 
(which we describe more fully in the next section). In essence, 
modern methods provide rich information about item perfor-
mance not available using traditional psychometric methods, 
that can be used to create banks of items (up to many hundreds 
or thousands of items) with known characteristics. New items 
can then be calibrated against the best available measures to 
obtain scales of higher quality and better precision.65 Item 
banking also makes it possible to carry out computer adap-
tive testing.66 In this technique, rather than giving the same 
set of items to each individual, the items are selected based 
on ability level or other characteristics. Computer adaptive 
testing has already been developed in many areas includ-
ing migraine, combining datasets using different outcome 
measures.67
As alluded to in this last paragraph, the increased appli-
cation of rating scales in health measurement has required 
the introduction of more advance psychometric methods. 
To elaborate on this, we first need to place these “newer” 
methods in context.
Psychometrics in health 
measurement: a brief history
Psychometrics was adopted as part of health measurement in 
the early 1980s.68–70 However, its scientific foundations are 
deeply rooted in education and psychology. In fact, its origins 
can be traced to the mid 1800s when psychophysicists were 
demonstrating that subjective judgment can be used as a 
valid approach to measurement.71,72 Through the advent of 
the mental test movement (circa 1925–1960),30 these ideas 
were taken further and, as such, Thurstone proposed the “law 
of comparative judgment”, an approach with close connec-
tions to the psychophysical theory developed by Weber and 
Fechner. This demonstrated that psychophysical scaling 
methods could be used to measure psychological attributes 
accurately27,73 and prompted the development of psychologi-
cal (or psychometric) scaling methods, which are defined as 
procedures for constructing scales for the measurement of 
psychological attributes.71 The mental test movement led to 
the widespread use of standardized tests (eg, educational 
achievement, attitudes and personality, personnel) and, at the 
same time, scientific interest in methods of testing led to the 
development of psychometrics as a prominent discipline in 
psychology, within which were established the cornerstones 
of the scientific evaluation of measures.71,74
As explained above, since the 1970s health care evalu-
ation has moved towards the measurement of physical, 
psychological, and social functioning.25 The importance 
of psychometric methods for measuring health variables 
was demonstrated by two related key studies conducted 
in the US. First, the Health Insurance Experiment75 showed 
that psychometric methods could be used to generate reliable 
and valid measures for assessing changes in health status for 
both adults and children in the general population. Second, 
the Medical Outcomes Study25,76 showed that psychometric 
methods of scale construction and data collection were suc-
cessful for measuring health status in samples of sick and 
elderly people. Since then, the use of psychometrics has 
proliferated throughout health measurement.
Psychometric methods
The main psychometric approaches as related to health mea-
surement have been classical test theory and, more recently, 
Rasch measurement models and item response theory. Of 
all three approaches, classical test theory is currently the 
dominant paradigm.
Classical test theory
Spearman laid down the foundations of classical test theory 
in 1904, when he introduced the decomposition of an 
observed score into a true score and an error, and showed 
how to estimate the reliability of observed scores.77 It took 
a further 50 years before the role of classical test theory 
analyses became clearer78 as an accumulation of statistical 
evidence to establish the scientific robustness of measures 
(eg, Kuder-Richardson’s coefficients for internal inconsis-
tency, Cronbach’s alpha, correlations between replicated 
measurements). Classical test theory is grounded in the 
definition of measurement as proposed by Stevens (ie, “the 
assignment of numerals to objects or events according to 
some rule”).79 It is important to note that this definition dif-
fers in important respects from the more classical definition 
of measurement adopted throughout the physical sciences, 
which is that measurement is the numerical estimation and 
expression of the magnitude of one quantity relative to 
another.80 Classical test theory is based upon analyses of 
raw scores that are used to test the assumptions underlying a Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
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given measurement model, ie, that the items can be summed 
(without weighting or standardization) to produce a score. 
The key traditional measurement properties that should be 
considered are data quality, scaling assumptions, targeting, 
reliability, validity, and responsiveness. We and others 
describe these tests in more detail elsewhere.2,14
Rasch measurement methods
Georg Rasch, a Danish mathematician, was principally 
concerned with the measurement of individuals rather than 
distribution of levels of a trait in a population. He argued 
that the core requirement of social measurement should be 
the same as that in physical measurement (ie, “invariant 
comparison”). With this in mind, he developed the simple 
logistic model (now known as the Rasch model) and through 
applications in education and psychology, he was able to 
demonstrate that his approach met the stringent criteria 
for measurement used in the physical sciences.81 Vitally, 
the Rasch paradigm differs from the traditional statistical 
modeling paradigm, in that the latter approach is used to 
describe a set of data, whereas the former aims to obtain 
data which fit the model.82
In the Rasch model, the probability of a specified response 
to a given item (eg, “yes”/”no”) is modeled as a logistic func-
tion of the difference between the person and item parameter 
(ie, the higher a person’s ability with respect to the difficulty 
of an item, the higher the probability of a correct response). 
When applying the Rasch model, item locations are scaled 
first in a process known as “item calibration”. Once item 
locations are scaled, the person locations are measured on 
the same scale. Each item and person estimate has an asso-
ciated standard error of measurement, which quantifies the 
associated degree of uncertainty.
Rasch measurement methods are able to transform 
ordinal summed scores into linear measurements by paired 
comparisons of any two persons, any two items, or any one 
person and one item, defined by the logarithm of the relative 
probabilities.81,83,84 Essentially, observed scores are replaced 
by the expected probabilities of occurrence, and relative dif-
ferences are computed as ratios of the relative probabilities 
(as these are consistent indicators of relative differences). 
This ratio of the relative probabilities is then expressed 
on a linear scale in an additive form by taking logarithms. 
In addition, the Rasch model is able to transform summed 
scores into linear measures of persons and items that are on 
the same scale with a common unit, and freed up from the 
distributional properties of each other. Thus, the Rasch model 
realizes, mathematically, the requirements for   scientific 
  measurement of invariant comparisons of people, and items, 
on the same linear scale.81 83,84
Rasch measurement methods use the Rasch model 
to evaluate the legitimacy of summing items to generate 
measurements, and their reliability and validity. The model 
articulates the set of requirements that must be met for rat-
ing scale data to generate internally valid, equal-interval 
measurements that are stable (invariant) across items and 
people.85 The central tenet of the Rasch measurement 
methods is that they examine the extent to which observed 
data (patients’ actual responses to scale items) accord with 
(“fit”) predictions of those responses from a mathematical 
(Rasch) model. Thus, the difference between what should 
happen (expected) and what does happen (observed) indi-
cates the extent to which rigorous measurement is achieved. 
Statistical and graphical tests are used to evaluate the cor-
respondence of data with the model. Certain tests are global, 
while others focus on specific items or persons. There are 
seven key measurement properties that should be considered, 
ie, thresholds for item response options, item fit statistics, 
item locations, differential item functioning, correlations 
between standardized residuals, person separation index, 
and individual person change statistics. We describe these 
in more detail elsewhere.14
Comparison of classical test theory  
and Rasch measurement
Direct comparisons of classical test theory and Rasch mea-
surement methods in the medical literature are sparse, and 
at best superficial.86,87 In part, this may be due to the fact that 
the two approaches cannot be compared easily, because they 
use different methods, produce different information, and 
apply different criteria for success and failure.
There are four main limitations of classical test theory. 
First, the data generated are ordinal rather than interval, 
the invariance of which is unknown.85 Second, scores for 
persons and samples are scale-dependent because they 
lack the provision for varying item parameters, resulting 
in item parameters that must be regarded as fixed.88 Third, 
scale properties, such as reliability and validity, are sample-
dependent. As such, the marginal probabilities of measures 
(ie, the probability distribution of scale scores) vary across 
population subgroups, because these subgroups may vary in 
the rate of the construct being measured.11 Fourth, the data 
are only suitable for group studies, and are not suitable for 
individual patient measurement.89
Rasch measurement methods address each of the four lim-
itations of classical test theory. First, the approach offers the Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
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ability to construct linear measurements from   ordinal-level 
rating scale data, thereby addressing a major concern of 
using rating scales as outcome measures.90,91 Second, Rasch 
measurement methods provide item estimates that are free 
from the sample distribution and person estimates that are 
free from the scale distribution, thus allowing for greater flex-
ibility in situations where different samples or test forms are 
used.92 Therefore, the methods allow for the use of subsets of 
items from each scale rather than all items from the scale, yet 
are still able to compare scores using different sets of items. 
This is the foundation for item banking and computerized 
adaptive   testing.66 Third, Rasch measurement methods enable 
estimates to be obtained suitable for individual person analy-
ses rather than only for group comparison studies.84,93
Criticisms of the Rasch model include it being overly 
restrictive because it does not permit each item to have a dif-
ferent discrimination and because there is no provision in the 
model for other parameters (eg, guessing). Some also suggest 
that this model is also limited by the need for unidimensional 
data and is too simple to match the complexity of human 
behavior. Further, it is complex, and classical test theory test 
scoring procedures are simpler to compute.86,94–96
item response theory and Rasch 
measurement
Item response theory is another body of psychometric analy-
sis that provides a foundation for statistical estimation of 
parameters that represent the locations of persons and items 
on a latent continuum.97 In particular, item response theory 
analyses are used to ascertain the degree to which a given 
model and parameter estimates can account for the struc-
ture of and statistical patterns within a response dataset.82,97 
Rasch measurement methods and item response theory are 
mathematically similar and, therefore, are often considered as 
members of the same family of statistical techniques.82,98 This 
is inaccurate because practitioners of Rasch measurement 
methods and item response theory have different research 
agendas.23,82,98
The distinction between Rasch measurement methods and 
item response theory is subtle but important. Item response 
theory models are statistical models used to explain data, 
and as such, the aim of an item response theory analysis is 
to find the statistical model that best explains the observed 
data.82,98 When the observed data do not fit the chosen item 
response theory model, we seek another model to explain the 
data better. In contrast, Rasch measurement methods provide 
a mathematical model for guiding the construction of stable 
linear measures from rating scale data.81 Therefore, the aim 
of Rasch measurement methods is to determine the extent 
to which observed rating scale data satisfy the measurement 
model. When the data do not fit the model, we examine the 
data carefully to try and explain the misfit, but ultimately 
we choose data that satisfies the model’s requirements. This 
is the central tenet of the Rasch model that distinguishes it 
from item response theory models. Specifically, its defining 
property is its mathematical embodiment of the principle of 
invariant comparison.
The above discussion invokes two questions, ie, which 
approach is better and does it matter which approach is 
used? The answers to both questions depend on which 
central philosophy is followed, because this divides pro-
ponents of item response theory and Rasch measurement. 
Because item response theory prioritizes the observed data, 
it sees the Rasch perspective of using only one model as too 
restrictive, and the “selection” of data to meet that model as 
threatening to content validity.99,100 Because Rasch measure-
ment prioritizes the mathematical model, it sees the process 
of modeling data as precluding the ability to achieve core 
requirements of measurement, too accepting of poor quality 
data, and threatening to construct validity. Not surprisingly, 
it has been suggested that item response theory and Rasch 
measurement have irreconcilable differences,101 and the two 
groups have come into conflict regarding which approach is 
preferable.82,102–104
Problem: our understanding  
of exactly what rating scales  
are measuring is limited
We hope that, in the previous sections, we have made the 
case for the strong scientific basis that underpins the area 
and the progress that has been made, especially over the last 
50 years. We also hope that we have illustrated some of the 
potential pitfalls, especially in the selection of appropriate 
scales and use of appropriate psychometric methods. In fact, 
it is our experience that the most common   disagreements 
in health measurement surround the issues of methods and 
methodology. We also expect that the debate surrounding the 
relative merits of competing psychometric approaches will 
continue. This is an issue for health measurement but, over 
time, and with enough discussion and clarification, we hope 
that this situation will improve.   However, in our opinion, there 
is a more pressing and fundamental problem that needs to be 
addressed in health measurement.
The rise in profile of health measurement requires   rating 
scales that measure the health constructs they   purport 
to   measure (ie, are valid), and health constructs that are Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
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  clinically meaningful and interpretable. Unfortunately, the 
current methods of establishing rating scale validity rarely 
enable these goals to be confirmed, because they lack formal 
methods for defining and testing construct theories.105 This 
situation has arisen, in part, because the constructs measured 
by many scales are determined during their development.
Typically, scale developers generate a large pool of 
items, group them into potential scales, either statistically 
or thematically, decide what construct each group seems 
to measure, and then remove unwanted or irrelevant items. 
The main limitation of this approach is that the scale content, 
rather than the construct intended for measurement, defines 
what the scale measures. Neither grouping items statistically, 
nor thematically, ensures that the items in a group measure 
the same construct. Furthermore, both methods of group-
ing items do not adequately address the issues of defining, 
conceptualizing, and operationalizing constructs, which are 
central to valid measurement.106–109 Even if the circumstances 
were different, and scales were underpinned by explicit con-
struct theories, standard methods of validity testing would not 
enable those theories to be tested adequately. Why? Because 
current methods, which integrate evidence from nonstatistical 
and statistical tests, provide circumstantial evidence at best 
that a set of items is measuring a specific construct.
Nonstatistical tests of validity typically consist of 
assessments of content and face validity. Content validation 
assesses whether scale development has sampled all the 
relevant or important content or domains,110 uses “sensible 
methods of scale construction”, and a “representative col-
lection of items”.111 Face validation assesses whether the 
final scale looks, on the face of it,110 like it measures what 
is intended.111 Over 50 years ago, Guilford named these 
evaluations “validity by assumption” and “faith validity”,71 
yet they remain essentially unchallenged, except, perhaps 
for Feinstein’s contribution of clinimetrics.24
Statistical tests of scale validity are more formal than their 
nonstatistical counterparts, but remain weak evaluations of 
the extent to which a set of items measures a construct. For 
example, statistical examinations of internal construct valid-
ity (eg, factorial validity112 and internal consistency113) test the 
extent to which the items of a scale are related   statistically. 
This does not confirm that a set of items marks out a clini-
cally meaningful variable of interest, let alone tell us what 
a scale measures.
Statistical tests of external construct validity consist of 
a range of examinations (including correlations with other 
measures,114,115 testing known group differences,116 and 
hypothesis testing113,114) which assess the extent to which 
scale scores “behave” as predicted, and seek to determine if 
a scale “does what it is intended to do”.74 The examination 
considered to provide the strongest statistical evidence of 
scale validity is called convergent and discriminant construct 
validity.115 Here, a range of scales measuring similar and dis-
similar constructs are administered to a sample. Their scores 
are correlated, and the pattern and magnitude of correlations 
are examined to determine if the scale being validated cor-
relates better with scales measuring similar constructs than 
dissimilar constructs. The limitation of this approach is that 
showing a scale does not correlate highly with measures of 
a dissimilar construct tells us nothing about what the scale 
actually measures. Similarly, showing that a scale correlates 
highly with measures of similar constructs only tells us that 
the two are related.
A key problem with all statistical tests of validity is that 
they focus on person scores and between-person variation in 
these scores. They are weak because there is no independent 
means of assessing the extent to which the intention of the scale 
is attained.117 Consequently these validation techniques entail 
circular reasoning,117 generate only circumstantial evidence of 
validity,98 enable limited development of construct theories, 
and result in “primitive” understandings of exactly what is 
being measured.105 Like their nonstatistical counterparts, they 
have remained essentially unchallenged for decades.
Can we solve the problem?
Encouragingly, PRO guidelines, such as the current scien-
tific requirements of the US Food and Drug Administration 
(FDA) for patient-reported rating scales in clinical trials,2,118 
highlight the importance of establishing validity. In particular, 
the FDA emphasizes appropriate conceptual frameworks 
and definitions as being fundamental. However, the FDA 
document provides little detailed guidance on how these can 
be achieved, largely because the field is poorly developed. 
We would argue that greater use of qualitative assessments 
is vital, and should include evaluating the extent to which 
the items of a scale map out the construct to be measured, 
establishing the most appropriate item phrasing, structuring 
and context, and cognitive debriefing to ensure consistency 
in meaning. In particular, we advocate the use of inductive 
and deductive approaches to develop explicit theories of the 
constructs being measured, and explicit methods of testing 
those theories.105,117,119
Rating scale development would benefit from being 
“bottom-up” (from a construct definition), rather than 
“top-down” (from a method of grouping items) to ensure that 
a substantive construct theory determines scale   content, and Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
287
Problems with health measurement
validation tests construct theories. This would require the 
development of robust guidelines for defining constructs and 
explicit definitions for content and face validity.   Rating scale 
evaluation should fully acknowledge the equally important 
and complementary roles of qualitative and quantitative 
evaluations. In fact, scale evaluation could be considered 
under these two headings. The aim of qualitative evalua-
tion could be defined as determining the extent to which 
the items of a scale map out a construct as a clinically 
meaningful continuum and, when available, the extent to 
which construct theory is supported. The aim of quantita-
tive evaluation could be defined as determining the extent 
to which the numbers generated by scales are measurements 
rather than numerals.
This analysis of scale validity implies that two things are 
needed, ie, explicit theories of the constructs being measured 
and explicit methods of testing those theories. Over the last 
25 years, one group outside of health measurement has devel-
oped these ideas to an advanced level.105,117,119 This group, 
led by Stenner, has argued for a change in focus of assess-
ing validity from studying the people to the items,105 and in 
particular the relationships between item characteristics and 
item scores. This forms the building blocks of the theory of 
the construct, and the validity of the construct theory becomes 
established when it predicts variation in item scales values. 
Stenner asks three key questions: Why are items ordered 
in a particular way? How can we explain variation in item 
scores, (ie, item difficulty)? What is the “something” that 
causes this variation?
The approach of Stenner et al is illustrated by their Lexile 
framework for measuring people’s reading ability.119 The 
reading ability continuum is mapped out by a set of items, 
each of which is a passage of reading text with different levels 
of readability (reading difficulty). People’s responses to the 
items are scored to give a measure of their reading ability. The 
Lexile framework was constructed using Rasch measurement 
methods, thus people are measured in linear units (called 
  Lexiles), and legitimate individual person measurement is 
possible. Theory suggests that the reading difficulty of a 
passage of text (item difficulty) is determined by two char-
acteristics, ie, the frequency of the words as they are used in 
everyday written and oral communications, and the length of 
the sentences. These two variables combine in the form of a 
construct specification equation that consistently explains more 
than 80% of the variation in text difficulty.119 Thus, empirical 
evidence strongly supports the construct theory. Stenner calls 
this approach “theory-referenced measurement”.119 We provide 
more detail about his work elsewhere.23
There are currently no examples of scales developed using 
theory-referenced measurement in health measurement, but it 
would not be hard to imagine instances where we could apply 
this approach. One example could be measuring the impact of 
disability. We would argue that it should be possible to take 
any aspect of impact (eg, upper limb   functioning), and ask the 
same questions as Stenner’s group. Thus, why are upper limb 
physical functioning items ordered and separated as they are? 
What specific item characteristics (eg, task variables) deter-
mine item difficulties (eg, task abilities)? We could identify 
the motor components of tasks that may characterize a theory 
of upper limb functioning, and examine items to identify their 
characteristics (variables) that account for these task difficul-
ties. In doing so, we would begin to assemble the building 
blocks of a new construct theory and then move towards an 
appropriate construct specification equation.
Conclusion
In a 1997 editorial, Sonja Hunt, codeveloper of one of the first 
generic measures, ie, the Nottingham Health Profile,49 warns 
us about the dangers of using quality of life instruments for 
decision-making: “From the perspective of scientific method 
it seems that there is a considerable way to go before any of 
the existing models or ‘theories’ can be considered definitive 
enough to justify application in the lives of patients ... where 
the results may be used to guide decision-making in the real 
world is not only unscientific, it is unethical”. 47
Fourteen years later, we find ourselves in a position 
where the field now stretches far beyond quality of life, into 
all aspects of health, and clinician-report and patient-report 
rating scales are being used as part of the patient decision-
making process. However, in terms of the application of 
scientific methods to ensure that we have a clear understand-
ing of what we are measuring, much less progress has been 
made. Thus, whereas we feel the intention behind the use 
of rating scales as health measurement tools in high stakes 
decision-making is well meant, we believe that there is a way 
to go before we can be confident that these tools are provid-
ing accurate information about their target constructs. The 
potential consequences in terms of rating scales misguiding 
patient care and misleading research, we believe, are under-
appreciated by clinicians and researchers.
Although construct specification equations are some 
way off, a move towards developing consensus guidelines 
to strengthen the theoretical underpinnings of new scales 
and the evaluation of existing scales would benefit health 
  measurement. In particular, we would like to see greater 
use of qualitative assessments including: the adoption of Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
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  inductive and deductive approaches to construct theory 
building and development; evaluations of the extent to which 
the items of a scale mark out the construct to be measured; 
establishing the most appropriate item phrasing, structuring, 
and context; and cognitive debriefing to ensure consistency 
in meaning.
We have two key messages from our review. First, clinical 
researchers should be aware that there is a wealth of informa-
tion regarding psychometrics out there.   However, considered 
in isolation, psychometric statistics can be   misleading. They 
cannot be expected to produce consistently meaningful 
results when considered apart from qualitative scale content 
  evaluations. Second, establishing clinically meaningful 
content validity from the onset by defining, conceptualizing, 
and operationalizing the constructs intended to be measured 
is a vital step. Unfortunately, in health measurement, such 
strong conceptual underpinnings and therefore explicit con-
struct theories are uncommon,47 and clinicians, researchers, 
and policy makers should bear this in mind when engaging 
with health measurement at all levels. Stenner et al use the 
following analogy to describe a construct theory: “The story 
we tell about what it means to move up and down the scale 
for a variable of interest (eg, temperature, reading, ability, 
short-term memory). Why is it, for example, that items are 
ordered as they are on the item map? [This] story evolves as 
knowledge increases regarding the construct”.119 We would 
suggest that we need to be able to tell clearer and more 
detailed stories about what underpins our rating scales before 
we can start to use them confidently to make decisions about 
patient’s lives.
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